These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 8713802)

  • 21. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets.
    Phillips MD; Moake JL; Nolasco L; Turner N
    Blood; 1988 Dec; 72(6):1898-903. PubMed ID: 3264193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation.
    Boncler MA; Golanski J; Paczuski R; Watala C
    J Mol Med (Berl); 2002 Dec; 80(12):796-801. PubMed ID: 12483465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers.
    Weinstein M; Vosburgh E; Phillips M; Turner N; Chute-Rose L; Moake J
    Blood; 1991 Nov; 78(9):2291-8. PubMed ID: 1932745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions.
    Wagner CT; Kroll MH; Chow TW; Hellums JD; Schafer AI
    Biorheology; 1996; 33(3):209-29. PubMed ID: 8935180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice.
    Matsuno H; Kozawa O; Ueshima S; Matsuo O; Collen D; Uematsu T
    Br J Pharmacol; 2000 Oct; 131(4):858-64. PubMed ID: 11030738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
    Kang M; Wilson L; Kermode JC
    Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
    Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
    Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis model.
    Gurevitz O; Eldar M; Skutelsky E; Tamarin I; Shenkman B; Eskaraev R; Castel D; Loscalzo J; Inbal A
    Thromb Haemost; 2000 Nov; 84(5):912-7. PubMed ID: 11127876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated aurintricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery.
    Matsuno H; Kozawa O; Niwa M; Uematsu T
    Circulation; 1997 Aug; 96(4):1299-304. PubMed ID: 9286962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of antithrombotic effects of GPIIb-IIIa receptor antagonist and TXA2 receptor antagonist in the guinea-pig thrombosis model: possible role of TXA2 in reocclusion after thrombolysis.
    Takiguchi Y; Asai F; Wada K; Nakashima M
    Thromb Haemost; 1995 Apr; 73(4):683-8. PubMed ID: 7495079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new binding assay of von Willebrand factor and glycoprotein Ib using solid-phase biotinylated platelets.
    Hayata K; Nakayama T; Matsushita T; Sakano K
    J Pharmacol Sci; 2008 Oct; 108(2):217-21. PubMed ID: 18845909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shear stress-induced binding of von Willebrand factor to platelets.
    Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
    Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
    Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
    J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons.
    Fontayne A; Meiring M; Lamprecht S; Roodt J; Demarsin E; Barbeaux P; Deckmyn H
    Thromb Haemost; 2008 Oct; 100(4):670-7. PubMed ID: 18841291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the antithrombotic effect of aurintricarboxylic acid on arterial thrombosis in rats and guinea pigs.
    Takiguchi Y; Shimazawa M; Nakashima M
    Br J Pharmacol; 1996 Aug; 118(7):1633-8. PubMed ID: 8842425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.
    Spiel AO; Mayr FB; Ladani N; Wagner PG; Schaub RG; Gilbert JC; Jilma B
    Platelets; 2009 Aug; 20(5):334-40. PubMed ID: 19637097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.